Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes

Heather J. Bax(King's College London), Debra H. Josephs(Guy's and St Thomas' NHS Foundation Trust), Natalie Woodman(London Cancer), Mieke Van Hemelrijck(Ghent University Hospital), Sara Lombardi(Federico II University Hospital), Chara Stavraka(King's College London), Aida Santaolalla(King's College London), Silvia Crescioli(Unknown), Charleen Chan Wah Hak(Institute of Cancer Research), Silvia Mele(St Thomas' Hospital), Gabriel Osborn(Guy's Hospital), Lais C. G. F. Palhares(Guy's Hospital), James Spicer(King's College London), Silvana Canevari(Institute of Biomedical Technologies), Jack Coumbe(Guy's Hospital), Atousa Khiabany(King's College London), Jitesh Chauhan(King's College London), Cheryl Gillett(King's College London), Amy Pope(Guy's Hospital), Sophia N. Karagiannis(King's College London), Jacobo López‐Abente(Guy's Hospital), Mano Nakamura(King's College London), Sophia Tsoka(King's College London), Sadek Malas(Guy's Hospital), Kevin T. Fitzgerald(University of Colorado Boulder), Roman Laddach(Guy's Hospital), Alexandra Robinson(Guy's Hospital), Mariangela Figini(Fondazione IRCCS Istituto Nazionale dei Tumori), Rebecca Kristeleit(Guy's and St Thomas' NHS Foundation Trust), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Melanie Grandits(Guy's Hospital), Sharmistha Ghosh(Guy's and St Thomas' NHS Foundation Trust), Sarah E. Pinder(St Thomas' Hospital), Cristina Naceur‐Lombardelli(Cancer Research UK), Anna M. Black(Guy's and St Thomas' NHS Foundation Trust), Ahmad Sayasneh(Imperial College Healthcare NHS Trust)
British Journal of Cancer
November 19, 2022
Cited by 89


Related Papers